Literature DB >> 27613991

Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation).

Cécile Picard1, Guillaume Thouvenin2, Caroline Kannengiesser3, Jean-Christophe Dubus4, Nadia Jeremiah5, Frédéric Rieux-Laucat5, Bruno Crestani6, Alexandre Belot7, Françoise Thivolet-Béjui8, Véronique Secq9, Christelle Ménard10, Martine Reynaud-Gaubert11, Philippe Reix12.   

Abstract

We report three cases of pulmonary disease suggesting fibrosis in two familial and one sporadic case. Pulmonary symptoms were associated with various clinical features of systemic inflammation and vasculitis involving the skin, and appeared at different ages. A strong interferon signature was found in all three cases. Disease was not responsive to corticosteroids, and lung transplantation was considered for all three subjects at an early age. One of them underwent double-lung transplantation, but she immediately experienced a primary graft dysfunction and died soon after. Recognized causes of familial interstitial lung disease were all excluded. All three subjects had a mutation in the previously described autoinflammatory disease called SAVI (stimulator of interferon genes [STING]-associated vasculopathy with onset in infancy). These cases emphasize the need to consider this possibility in children and young adults with lung fibrosis after common causes have been ruled out.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  TMEM173; autoinflammatory disease; pulmonary fibrosis; vasculopathy

Mesh:

Substances:

Year:  2016        PMID: 27613991     DOI: 10.1016/j.chest.2016.02.682

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  31 in total

Review 1.  Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.

Authors:  Hirotsugu Oda; Daniel L Kastner
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

Review 2.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

Review 3.  [Familial chilblain lupus : Type 1 interferonopathy with model character].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

4.  Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models.

Authors:  Mona Motwani; Sudesh Pawaria; Jennifer Bernier; Stephanie Moses; Kate Henry; Terry Fang; Linda Burkly; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-03       Impact factor: 11.205

Review 5.  Familial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?

Authors:  Christoph Fiehn
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

Review 6.  The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.

Authors:  Keesha M Matz; R Marena Guzman; Alan G Goodman
Journal:  Int Rev Cell Mol Biol       Date:  2018-09-25       Impact factor: 6.813

Review 7.  [Autoinflammation-differences between children and adults].

Authors:  Martin Krusche; Tilmann Kallinich
Journal:  Z Rheumatol       Date:  2021-11-11       Impact factor: 1.372

8.  The Challenge of Diagnosing SAVI: Case Studies.

Authors:  Yao Cao; Li-Ping Jiang
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-12-11       Impact factor: 1.349

Review 9.  STING-Mediated Lung Inflammation and Beyond.

Authors:  Marie-Louise Frémond; Yanick J Crow
Journal:  J Clin Immunol       Date:  2021-02-02       Impact factor: 8.317

Review 10.  The relationship between defects in DNA repair genes and autoinflammatory diseases.

Authors:  Demet Kivanc; Selcuk Dasdemir
Journal:  Rheumatol Int       Date:  2021-06-06       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.